NPM1 and acute myeloid leukemia: Our data implies that treatment with EAPB02303 upregulates ARF to induce NPM1 SUMOylation, thereby antagonizing the NPM1-mediated ribosomal biogenesis in NPM1c-AML, necessitating future investigations.